About Shlomi Nachman
Shlomi Nachman serves on AngioInsight's board. The company develops investigational AI software that helps cardiologists evaluate angiograms for coronary artery and small-vessel disease. He has more than 25 years of global cardiovascular medical-technology leadership. He formerly served as worldwide chairman of Johnson & Johnson's Cardiovascular and Specialty Solutions group. He oversaw $9 billion in annual revenue there.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Shlomi Nachman in the role, so the role may have started earlier or lasted longer.
AngioInsight, Inc. Current
Director
2025 – Present · Minnetonka, MN
Its investigational software helps cardiologists assess artery narrowing, blood flow, and small-vessel disease from routine angiograms.
JC
Johnson & Johnson’s Cardiovascular and Specialty Solutions (CSS)
Worldwide Chairman
Key Colleagues at Startups
The people Shlomi Nachman works with at each company, as listed on that company's latest Form D.
AngioInsight, Inc. · Form D, Nov 10, 2026
Scott Burger
Chief Executive Officer and director
Laurence Betterley
Director
Serafin Samson
Co-Founder and director
Mark Summers
Chairman